Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.4 (
deaminase
)
5,113
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
APOBEC-1, which mediates the editing of apolipoprotein (apo) B mRNA, is the only known member of the C (cytidine)-->U (uridine) editing enzyme subfamily of the cytidine deaminase supergene family. Here we report the cloning of
APOBEC-2
, another member of the subfamily. Human and mouse
APOBEC-2
both contain 224 amino acid residues, and their genes are mapped to syntenic regions of human chromosome 6 (6p21) and mouse chromosome 17. By phylogenetic analysis,
APOBEC-2
is shown to be evolutionarily related to APOBEC-1, and analysis of substitution rates indicates that
APOBEC-2
is a much better conserved gene than APOBEC-1.
APOBEC-2
mRNA and protein are expressed exclusively in heart and skeletal muscle.
APOBEC-2
does not display detectable apoB mRNA editing activity. Like other editing enzymes of the cytidine deaminase superfamily,
APOBEC-2
has low, but definite, intrinsic cytidine deaminase activity. The identification of
APOBEC-2
indicates that APOBEC-1 is not the only member of the C-->U editing enzyme subfamily, which, like the A (adenosine)-->I (inosine) subfamily of editing enzymes, must encompass at least two and possibly more different
deaminase
enzymes. It suggests that the C-->U editing affecting apoB mRNA and other RNAs is not an isolated event mediated by a single enzyme but involves multiple related proteins that have evolved from a primordial gene closely related to the housekeeping enzyme cytidine deaminase.
...
PMID:APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family. 1040 81